Baltimore-Washington Financial Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Baltimore-Washington Financial Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-750	Closed	-$21K	–	342
2014 Q2	$21K	Buy	+750	New	+$20K	0.01%	211
2014 Q1	–	Sell	-68,040	Closed	-$1.99M	–	306
2013 Q4	$1.99M	Sell	68,040 -180	-0.3%	-$5.71K	0.67%	65
2013 Q3	$2.09M	Buy	68,220 +2,085	+3%	+$69.7K	0.83%	53
2013 Q2	$2.1M	Buy	+66,135	New	+$2.17M	0.91%	52

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baltimore-Washington Financial Advisors's GHDX Position: Q3 2014 in Review

Baltimore-Washington Financial Advisors sold out of Genomic Health, Inc. (GHDX) in Q3 2014, closing a stake of 750 shares — an estimated $21K sold.

Baltimore-Washington Financial Advisors first reported a position in GHDX in Q2 2013 and held it in 4 quarters. The position peaked at $2.1M in Q2 2013. 107 funds tracked by Wall St. Rank hold GHDX as of Q3 2014.

Baltimore-Washington Financial Advisors reported no remaining Genomic Health, Inc. position as of Q3 2014 after selling out during the quarter.
Baltimore-Washington Financial Advisors sold 750 Genomic Health, Inc. shares in Q3 2014, an estimated $21K.
Baltimore-Washington Financial Advisors first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 4 quarters.
Baltimore-Washington Financial Advisors's Genomic Health, Inc. position peaked at $2.1M in Q2 2013.
107 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2014.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q3 2014, filed 29 Oct 2014.